Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Seishima

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
The British Journal of Dermatology|June 1, 1994
Serum lipid and apolipoprotein levels in patients with psoriasisM Seishima, M Seishima, S Mori, et al.
Nihon Hifuka Gakkai Zasshi. the Japanese Journal of Dermatology|May 1, 1989
[A case of psoriasis vulgaris whose lipoprotein lipase activity decreased during treatment with etretinate]M Seishima, S Mori, M Seishima, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 1, 1995
[Lipoprotein-X (LP-X)]M Seishima
The British Journal of Dermatology|January 1, 1995
Apo E phenotype does not contribute to the pathogenesis of psoriasisM Seishima, M Seishima, S Hua, et al.
Dermatology (Basel, Switzerland)|June 11, 1998
Increased serum soluble Fas, tumor necrosis factor alpha and interleukin 6 concentrations in generalized pustular psoriasisM Seishima, M Seishima, M Takemura, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 1, 1989
[Significance of lipoprotein-X analysis in clinical tests]M Seishima, A Noma
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 31, 1987
An increased apo A-IV serum concentration of patients with chronic renal failure on hemodialysisM Seishima, Y Muto
The British Journal of Dermatology|November 1, 1994
Etretinate administration reduces serum propeptide of type I procollagen level in patients with psoriasisK Osada, M Seishima, S Mori, et al.
Metabolism: Clinical and Experimental|October 1, 1993
Compensatory increase in intestinal apolipoprotein A-IV mRNA levels in the experimental nephrotic ratM Seishima, A Noma
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 16, 2001
[Lipoprotein X]M Seishima, F Hua
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
The British Journal of Dermatology|June 1, 1994
Serum lipid and apolipoprotein levels in patients with psoriasisM Seishima, M Seishima, S Mori, et al.
Nihon Hifuka Gakkai Zasshi. the Japanese Journal of Dermatology|May 1, 1989
[A case of psoriasis vulgaris whose lipoprotein lipase activity decreased during treatment with etretinate]M Seishima, S Mori, M Seishima, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 1, 1995
[Lipoprotein-X (LP-X)]M Seishima
The British Journal of Dermatology|January 1, 1995
Apo E phenotype does not contribute to the pathogenesis of psoriasisM Seishima, M Seishima, S Hua, et al.
Dermatology (Basel, Switzerland)|June 11, 1998
Increased serum soluble Fas, tumor necrosis factor alpha and interleukin 6 concentrations in generalized pustular psoriasisM Seishima, M Seishima, M Takemura, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 1, 1989
[Significance of lipoprotein-X analysis in clinical tests]M Seishima, A Noma
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 31, 1987
An increased apo A-IV serum concentration of patients with chronic renal failure on hemodialysisM Seishima, Y Muto
The British Journal of Dermatology|November 1, 1994
Etretinate administration reduces serum propeptide of type I procollagen level in patients with psoriasisK Osada, M Seishima, S Mori, et al.
Metabolism: Clinical and Experimental|October 1, 1993
Compensatory increase in intestinal apolipoprotein A-IV mRNA levels in the experimental nephrotic ratM Seishima, A Noma
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 16, 2001
[Lipoprotein X]M Seishima, F Hua
Pageof 14